Reuters: Regulatory News: US FDA approves Astellas drug for leaky bladder

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

US FDA approves Astellas drug for leaky bladder Jun 28th 2012, 17:52 WASHINGTON, June 28 | Thu Jun 28, 2012 1:52pm EDT WASHINGTON, June 28 (Reuters) - U.S. drugs regulators gave the nod to Astellas Pharma Inc's pill for overactive bladder on Thursday, boosting the Japanese drugmaker's foothold in the market for the condition. The Food and Drug Administration approved the once-daily pill, mirabegron, for adults who cannot control their bladder muscles, following a positive recommendation from FDA advisers.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions